Every Smile Is Special: Sparkling Charms Dental Studio Highlights Sensory-Friendly Pediatric Dental Program for Children With Special Needs in Baltimore
Baltimore, MD, Feb. 01, 2026 (GLOBE NEWSWIRE) -- Sparkling Charms Dental Studio,…
Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja (leniolisib) in children aged 4 to 11 years with APDS
Leiden, the Netherlands, February 1, 2026: Pharming Group (Euronext: PHARM; Nasdaq: PHAR)…
ALK receives positive recommendation for EURneffy 1 mg: A needle-free anaphylaxis treatment for children
Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the…
Grand Marathon Under Mumbai Climate Week Mobilizes Over 1,500 Students and Children for Climate Action
MUMBAI, India, Jan. 27, 2026 /PRNewswire/ -- In the run up to…
Real-World Commercial Experience with Ryoncil Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
January 26, 2026 18:45 ET | Source: Mesoblast Limited NEW YORK, Jan.…
CGTN: China, ROK to strengthen exchanges on welfare for women and children
BEIJING, Jan. 7, 2026 /PRNewswire/ -- CGTN published an article focusing on…
Plum Tree Launches 2026 with Expanded Access to Mental Health Care for Children and Adolescents
ST. CHARLES, Ill., Jan. 05, 2026 (GLOBE NEWSWIRE) -- As families enter…
Press Release: Sanofi and Regenerons Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to…
Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
Approval based on global Phase 3 program in children demonstrating Dupixent significantly…
Vantage Foundation Spreads Festive Cheer to Children with Starlight Sydney Initiative
SYDNEY, Dec. 18, 2025 /PRNewswire/ -- Vantage Foundation reaffirmed its commitment to…
